Revenue in the Cold & Cough Remedies market is projected to reach US$61.71m in 2024. Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.34%, resulting in a market volume of US ...
The study focused on assessing oral nalbuphine extended release for cough relief in idiopathic pulmonary fibrosis patients. A randomized, double-blind, placebo-controlled trial design was employed ...